DRKS00000205招募中1 期
Adoptive immune therapy of chemotherapy-refractory CMV-infection with Streptamer-selected T-cells after allogeneic bone marrow- or peripheral blood stem cell transplantation - AIT-CMV-Stage-01
Stage Pharmaceuticals GmbH0 个研究点目标入组 30 人开始时间: 2009年9月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •patient planned for or after allogeneic bone marrow or peripheral blood stem cell transplantation with a chronic persistent CMV infection refractory to antiviral chemotherapy,
- •reagents for HLA-type of patient available,
- •CMV seropositive donor,
- •patient agreed to participate in the trial
排除标准
- •missing written consent of patient and /or donor,
- •medication with > 1mg/kg Prednisolon,
- •acute or chronic Graft versus Host disease grade III or IV
研究者
相似试验
进行中（未招募）
不适用
Adoptive Immunotherapy of chemotherapy refractory CMV infections using Streptamer-isolated T cells after allogeneic bone marrow or peripheral blood stem cell transplantation: a phase I/II trial - AIT-CMV-Stage-01-chronic persistent CMV infection after allogeneic bone marrow or peripheral blood stem cell transplantation, refractory to antiviral chemotherapyEUCTR2006-006146-34-DEStage Pharmaceuticals GmbH30
已完成
1 期
T-cell Therapy for CMV (Cytomegalovirus) DiseaseCMV diseaseInfection - Other infectious diseasesACTRN12609000531213Queensland Institute of Medical Research30
尚未招募
2 期
In patients with the cancer called Hodgkins lymphoma we are trying to see whether adding a medicine stimulating the immune system will increase the benefit of usual treatmentCTRI/2023/11/060108Jawaharlal Institute of Postgraduate Medical Education and Research JIPMER
招募中
2 期
CHemotherapy And Sequential ImmunoTherapy for locally advanced urothelial cancer: the CHASIT studybladder/upper urinary tract/urethra cancerUrothelial cancer10038364NL-OMON53642Erasmus MC, Universitair Medisch Centrum Rotterdam58
招募中
1 期
CHemotherapy And Sequential ImmunoTherapy for locally advanced urothelial cancer: the CHASIT studyrothelial cancer of the bladder, upper urinary tract or urethra.MedDRA version: 20.0Level: LLTClassification code 10046714Term: Urothelial carcinoma bladderSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10046723Term: Urothelial carcinoma ureterSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10046728Term: Urothelial carcinoma urethraSystem Organ Class: 100000004864EUCTR2022-000514-33-NLErasmus MC58